Status:
WITHDRAWN
A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets
Lead Sponsor:
Pfizer
Conditions:
Therapeutic Equivalency
Eligibility:
All Genders
21-55 years
Phase:
PHASE1
Brief Summary
A study to determine whether a new formulation of methylprednisolone suspension is bioequivalent to methylprednisolone tablets.
Eligibility Criteria
Inclusion
- Healthy male or female subjects between the ages of 21 and 55 years.
- Body Mass Index (BMI) of 17.5 to 30.5 kg/m2 and a total body weight \> 45 kg (99 lbs).
Exclusion
- Any condition possibly affecting drug absorption (eg, gastrectomy).
- A positive urine drug screen
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01405131
Start Date
January 1 2012
End Date
February 20 2012
Last Update
October 30 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.